Novel Biomarker Strategies to Improve the Success of Drug Discovery
Biomarkers are measurable indicators (e.g., a molecule, gene, or characteristic) that can identify a particular physiological process or disease in the body.
Biomarkers can be applied to any disease, and while symptoms in patients are often subjective, they provide an objective, measurable and robust way to characterise a disease.
Measuring biomarkers can help predict, diagnose, and monitor disease and can identify how well the body responds to treatments.
Dr Michael Eyres, Lead Scientist at MDC, has been working on applying MDC’s biomarker expertise to a novel approach in drug discovery.
Video case study with Dr Emma Jones, Lead Scientist and Dr Eve Corrie, Senior Scientist. Neuronal activity assays at Medicines Discovery Catapult.
Video case study: Catherine Eagle, Lead Scientist in Immunology at Medicines Discovery Catapult, shares a real-world case study from MDC’s discovery labs.
